american drug prices

Printer-friendly version
FDA approval may spell trouble for Canadian patients

In 2022, the United States accounted for 42.6 per cent of pharmaceutical sales worldwide compared to 2 per cent for Canada.

Printer-friendly version
Canada's free ride on U.S. drug development may end soon

In a bid to get even steeper drug discounts, Health Canada recently proposed changes to our reference-pricing system.

Printer-friendly version

In January, GlaxoSmithKline, a global pharmaceutical manufacturer, announced that it would stop delivering its prescription drugs to wholesalers that supply Canadian mail order pharmacies that sell to American patients. These pharmacies, clustered in Manitoba, take advantage of the price difference between the two countries. Recently, AstraZeneca, an Anglo-Swedish pharmaceutical manufacturer, indicated that it would take similar action. Glaxo has weathered a storm of accusations that it is preventing American patients from getting the company’s medicines at affordable prices.